New: @mbkoltai et al. Public health interventions based on #vaccination or monoclonal antibodies against #RSV disease in infants in two African countries may be cost-effective: https://t.co/JC2oldrMxy @nicd_sa @cmmid_lshtm @WitsUniversity @KEMRI_Wellcome
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa https://t.co/gVnFew6yQ5
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa https://t.co/grffaMJqnK